Health
Andrew and Nicola Forrest’s Mindaroo an investor in COVID nasal spray developed by Hunter researcher Nathan Bartlett – Armidale Express
A nasal spray that could stop COVID-19 and the common cold in its tracks is one step closer to market after $32 million funding…
Hope: Hunter researcher Nathan Bartlett led studies into a nasal spray treatment that could prevent COVID-19. The project has secured $32 million to start human clinical trials. Picture: Jonathan Carroll
Continue Reading
-
Business13 hours agoWhy did this ASX 200 healthcare stock crash 14% yesterday?
-
General21 hours agoRussia launches hundreds of drones and missiles against Ukraine in fresh attack
-
Business16 hours agoOwn Xero shares? Here are 3 key takeaways from its AGM
-
General13 hours agoPatients speak out after Brisbane doctor accused of ‘excessive’ pap smears, kissing woman on lips